Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Cross

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Vaccine|March 1, 1986
Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humansS J Cryz, P Mortimer, A S Cross, et al.
Pediatric Research|December 1, 1990
Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strainsK S Kim, A S Cross, B Kaufmann, et al.
Lymphokine and Cytokine Research|December 1, 1992
Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the ratK S Kim, C A Wass, A S Cross, et al.
The Journal of Experimental Medicine|June 1, 1989
Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infectionA S Cross, J C Sadoff, N Kelly, et al.
Journal of Medical Microbiology|January 1, 1996
Evaluation of a competitive ELISA method for the determination of Klebsiella O antigensM Trautmann, A S Cross, G Reich, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 1, 1996
Kinetics and dose dependence of macrophage colony-stimulating factor-induced proliferation and activation of murine mononuclear phagocytes in situ: differences between lungs, liver, and spleenT K Held, M E Mielke, M Unger, et al.
Infection and Immunity|December 24, 1998
Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1T K Held, X Weihua, L Yuan, et al.
American Journal of Clinical Pathology|May 1, 1983
A hospital-wide outbreak of septicemia due to a few strains of Staphylococcus aureusA S Cross, C H Zierdt, B Roup, et al.
Clinical and Experimental Immunology|May 1, 1989
Intravenous immune globulin impairs anti-bacterial defences of a cyclophosphamide-treated hostA S Cross, G Siegel, W R Byrne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 1997
Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemiaM C Roghmann, R J McCarter, J Brewrink, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Vaccine|March 1, 1986
Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humansS J Cryz, P Mortimer, A S Cross, et al.
Pediatric Research|December 1, 1990
Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strainsK S Kim, A S Cross, B Kaufmann, et al.
Lymphokine and Cytokine Research|December 1, 1992
Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the ratK S Kim, C A Wass, A S Cross, et al.
The Journal of Experimental Medicine|June 1, 1989
Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infectionA S Cross, J C Sadoff, N Kelly, et al.
Journal of Medical Microbiology|January 1, 1996
Evaluation of a competitive ELISA method for the determination of Klebsiella O antigensM Trautmann, A S Cross, G Reich, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 1, 1996
Kinetics and dose dependence of macrophage colony-stimulating factor-induced proliferation and activation of murine mononuclear phagocytes in situ: differences between lungs, liver, and spleenT K Held, M E Mielke, M Unger, et al.
Infection and Immunity|December 24, 1998
Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1T K Held, X Weihua, L Yuan, et al.
American Journal of Clinical Pathology|May 1, 1983
A hospital-wide outbreak of septicemia due to a few strains of Staphylococcus aureusA S Cross, C H Zierdt, B Roup, et al.
Clinical and Experimental Immunology|May 1, 1989
Intravenous immune globulin impairs anti-bacterial defences of a cyclophosphamide-treated hostA S Cross, G Siegel, W R Byrne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 1997
Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemiaM C Roghmann, R J McCarter, J Brewrink, et al.
Pageof 12